EdwardJamesPearsonMD
Hematology • Dallas, TXHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Physician
Dr. Pearson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3410 Worth St
Ste 400
Dallas, TX 75246Phone+1 214-370-1000Fax+1 214-370-1085
Education & Training
Baylor University Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2017- Baylor University Medical CenterResidency, Internal Medicine, 2011 - 2014
Texas A&M; Health Science Center College of MedicineClass of 2011
Certifications & Licensure
TX State Medical License 2014 - 2025
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) Start of enrollment: 2015 Dec 30
- A Study of TAK-659 in Combination With Venetoclax for Adult Participants With Previously Treated Non-Hodgkin Lymphoma Start of enrollment: 2018 Feb 16
- A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies Start of enrollment: 2020 Aug 07
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsThe Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program.A. E. Bunnell, C. A. Garby, Edward J. Pearson, S. A. Walker, Laura Panos
Journal of Genetic Counseling. 2017-02-01 - 14 citationsThe incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapyEdward J. Pearson, Anju Nair, Yahya Daoud, Joanne L. Blum
Breast Cancer Research and Treatment. 2017-01-09 - 5 citationsDisease-related mortality exceeds treatment-related mortality in patients with chronic myeloid leukemia on second-line or later therapy.Edward J. Pearson, Lisa J. McGarry, Smeet Gala, Christopher Nieset, M Nanavaty
Leukemia Research. 2016-04-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
